Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Immunotherapy drugs are showing considerable promise in clinical trials with cancer patients. They work by interfering with the way cancer cells use ...
U.K. Regulators Grant Early Access to Merck Skin Cancer Drug, but Where Is Northwest Bio? - TheStreet.com
The team has been using what is known as immunotherapy to fight ... It's not clear if CMV actually causes the cancer, but an anti-tumor vaccine that ...
This could potentially improve cancer immunotherapy and shrink tumors by allowing T lymphocytes and natural killer cells to preform their functions.
Advaxis, Inc. ADXS, +2.92% a clinical-stage biotechnology company developing cancer immunotherapies, announced today that the Gynecologic ...
Unituxin is only the third drug in history to receive initial FDA approval for treating pediatric cancer, and the first immunotherapy drug for children with ...
The study entitled “Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer” was published in Nature by ...
Care is STILL a postcode lottery, wait times hit 7-year high and cancer fund drugs axed
18,740 patients in January waited longer than six weeks for cancer tests
Reports found 'unacceptable' variation in cancer detection across England
NHS spends less on new cancer treatments than US, Spain and Scotland
Scientists have noted that the body's own immune system is among the best anti-cancer systems available. In fact, the immune system has been an ...
Skin cancer drug fast-tracked on NHS - BBC News
Cancer drug in early access scheme - Isle of Man Today
MELBOURNE researchers have discovered why the “serial killers” of the immune system remain attached to cancer cells after they fail to deliver their ...
This year a number of these therapies are targeted at fighting cancer. ... the power of the immune system to fight cancer and infectious disease.
... mouse and human DNA, is an antibody that sticks to the surface of the cancer-affected cells and uses the body's immune system to destroy the cells.
Children's Cancer Drug OKd by FDA - Newsmax
... cells to develop immunity to vaccines and disease, including cancer. ... If this does not happen it is extremely catastrophic for the immune system, ...
Skin cancer patients resistant to BRAF-inhibitors studied ... the tumors are growing and how active the immune system is in the tumor," said Kwong.
Pairing the PD-1 inhibitor with MVI-816 to stimulate the immune system may ... The trial will be conducted with an award from the Prostate Cancer ...
... rheumatoid arthritis, cardiovascular problems, diabetes, atherosclerosis, an impaired immune system, certain types of cancer, and even Alzheimer's ...
Red Hot
For Schimenti’s group, a clue about improving the HDR/NHEJ ratio came from past genome-editing studies of Drosophila embryos, in which researchers genetically inhibited a molecule (DNA ligase IV) involved in the NHEJ pathway. It so happened that a small-molecule inhibitor of that ligase, SCR7, was subsequently identified as a potential treatment for cancer; Schimenti’s group decided to try SCR7 instead of genetic perturbation. In a study of mouse embryos in which the group aimed to incorporate a two-base mutation into one gene, the addition of SCR7 improved the ratio of HDR:NHEJ from 1:10 to 1:2.5
A pancreatic cancer therapy that utilizes injections of antibodies can double the survival rate of patients and represents a breakthrough in treating the ...
Taiwan makes pancreatic cancer study breakthrough - Taiwan Today
As a high school sophomore in Crownsville, Maryland, Andraka, motivated by the loss of a dear family friend who died from pancreatic cancer, ...
“With a growing trend toward preoperative therapies for resectable and borderline resectable pancreatic cancer at the study institution as well as ...
Cancers arising from these tissues, called epithelial tissues, covering ... global pancreatic cancer market is projected to exceed $1.6 billion by 2017, ...
Propanc Helping to Unravel Mystery Associated with Carcinomas - PR Newswire (press release)
Washington, DC – (March 10, 2015) — As budget discussions heat up on Capitol Hill, the Deadliest Cancers Coalition, a collaboration of national ...
The urinalysis test application targets the VPAC1 protein, which are over expressed on prostate and bladder cancer cells shed in voided urine but not ...
In 2010, researchers at Lund University and the University of Gothenburg found that it could be used to treat bladder cancer patients. Scientists found ...
| The New Indian Express |
Cancer and stones: Prostate cancer in men, or bladder cancer in men or women can cause incontinence. In some cases, the cancer's treatment will ...
RAZOR is a multi-institutional, randomized, non-inferior, phase III trial that will enrol at least 320 patients with T1-T4, N0-N1, M0 bladder cancer with ...
Article using maintenance BCG after TUR in intermediate-high risk non-muscle invasive bladder cancer(NMIBC) and followed for effectiveness, local ...
FDA Approves First Biosimilar, Filgrastim-sndz (Zarxio)
The US Food and Drug Administration has approved filgrastim-sndz (Zarxio), a biosimilar of filgrastim (Neupogen), and the first such agent to be approved in the United States.
The US Food and Drug Administration has approved filgrastim-sndz (Zarxio), a biosimilar of filgrastim (Neupogen), and the first such agent to be approved in the United States.
Radioactive Iodine Overused in Papillary Thyroid Cancer
Despite well-established guidelines from the American Thyroid Association, radioactive iodine continues to be overused for some forms of thyroid cancer.
Despite well-established guidelines from the American Thyroid Association, radioactive iodine continues to be overused for some forms of thyroid cancer.
IGF2BP1 Gene Plays Big Role in Neuroblastoma
Expression of the IGF2BP1 gene was associated with more advanced tumors and decreased patient survival in neuroblastoma, suggesting its prognostic value.
Expression of the IGF2BP1 gene was associated with more advanced tumors and decreased patient survival in neuroblastoma, suggesting its prognostic value.
Factors Used for Prognosis in Advanced Cervical Cancer
A new study yielded nomograms for the assessment of locally advanced cervical cancer, with prognostic factors including histology, performance status, and others.
A new study yielded nomograms for the assessment of locally advanced cervical cancer, with prognostic factors including histology, performance status, and others.
Final Results of 9-Valent HPV Vaccine Show Extended Cancer Protection
Final results of the trial that led to FDA approval show that a new 9-valent HPV vaccine can reduce cases of HPV and cervical cancer.
Final results of the trial that led to FDA approval show that a new 9-valent HPV vaccine can reduce cases of HPV and cervical cancer.
Amonafide Regimen Not Superior to Standard Care in Secondary AML
Induction treatment for acute myeloid leukemia with amonafide L-malate/cytarabine failed to improve the rate of complete response over daunorubicin/cytarabine.
Induction treatment for acute myeloid leukemia with amonafide L-malate/cytarabine failed to improve the rate of complete response over daunorubicin/cytarabine.
MRD, Remission Independent Prognostic Factors for AML
In patients with AML, post-therapy parameters including minimal residual disease and remission were found to be independent prognostic factors for outcomes.
In patients with AML, post-therapy parameters including minimal residual disease and remission were found to be independent prognostic factors for outcomes.
Final Results of 9-Valent HPV Vaccine Show Extended Cancer Protection
Final results of the trial that led to FDA approval show that a new 9-valent HPV vaccine can reduce cases of HPV and cervical cancer.
Final results of the trial that led to FDA approval show that a new 9-valent HPV vaccine can reduce cases of HPV and cervical cancer.
Science Daily Cancer News
Patients treated with definitive concurrent chemotherapy and radiation therapy for stage III non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers.
Researchers combined the NSAID naproxen with the proton pump inhibitor omeprazole and found it reduced the incidence of bladder cancer in rats. The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds.
Tambahkan Komentar